Chicago cancer tech startup teams up with Mayo Clinic
Tempus, a Chicago-based cancer technology startup, has signed a partnership with the Mayo Clinic.
The company will provide genetic sequencing and analysis for 1,000 patients in two clinical trials involving cancer patients.
Tempus was formed a little more than a year ago and has about 100 employees. It’s located in the same
building as Groupon and several other companies co-founded by Eric Lefkofsky and business partner Brad Keywell. The company aims to help doctors choose the most effective treatments, based on the patient’s individual genetic profiles.
It has signed partnerships with several other university research centers, including Northwestern’s Lurie Cancer Center, Rush University Medical Center, the University of Pennsylvania’s Abramson Cancer Center and University of Michigan.